▪
II HCP Annual Conference ▪
Strengthening the competitiveness of the Portuguese health cluster:
New paradigms. Better opportunities.
30 November 2011 | Taguspark (Oeiras)
09:00 Registration
09:30 Conference opening
▪ Luís Portela | President, Health Cluster Portugal
▪ Fernando Leal da Costa | Secretary of State Assistant to the Minister for Health
09:45 Keynote address: “Portugal and the challenges of the EU and the globalization”
▪ João Salgueiro | Economist
10:15 Roundtable
“Access to financing and business models for companies in the health sector”
▪ Moderator: Álvaro Almeida | Professor, Faculdade de Economia da Universidade do Porto
▪ Keynote speaker: António Murta | President, Pathena
▪ João Barroca | General Manager, Bayer Portugal
▪ Joaquim Sérvulo Rodrigues | CEO, Espírito Santo Ventures
▪ Nuno Arantes Oliveira | CEO, Alfama; Member of the Board, HCP; President, P-Bio
▪ Pedro de Noronha Pissarra | President and CEO, Biotecnol
11:30 Coffee break
12:00 Roundtable
“Opportunities in the 7th Framework Programme (and upcoming Programmes) for the health
sector”
▪ Moderator: José Mário Leite | President, ALIA; President, NCURA Int. Region; Deputy Director, IGC
▪ Keynote speaker: Cornelis Vis | Policy Adviser, European Commission – BEPA
▪ Frank Heemskerk | CEO, RIMS – Research & Innovation Management Services
▪ Hicham Abghay | Healthcare Sector Group coordinator, Enterprise Europe Network
▪ Joana Camilo | National Contact Point – Health, Gabinete de Promoção do 7.º PQ de I&DT
▪ Stéphane Hogan | Head of Unit, Horizontal Aspects, Health, DG Research and Innovation, EC
1/2
Co-financed by:
▪
II HCP Annual Conference ▪
Strengthening the competitiveness of the Portuguese health cluster:
New paradigms. Better opportunities.
30 November 2011 | Taguspark (Oeiras)
13:15 Lunch
14:30 Opening
▪ Carlos Oliveira | Secretary of State for Entrepreneurship, Competitiveness and Innovation
15:00 Roundtable
“Innovation, Entrepreneurship and Technology Transfer.
The relationships between Academia and Industry, and between SMEs and large companies”
▪ Moderator: Peter Villax | Administrator, Hovione; Member of the Board, HCP
▪ Keynote speaker: Simcha Jong | Professor, University College London
▪ Edward Gates | Chairman, Wolf Greenfield
▪ Elvira Garcia-Hernando | General Manager, Lilly Portugal
▪ John R. Kettman | Director, Radix BioSolutions; Professor, Univ. Texas Southwestern Medical Center
▪ José Manuel Mendonça | President, INESC Porto
▪ Sérgio Simões | Vice-President, Bluepharma
17:00 Closing session
More information at
www.healthportugal.com
2/2
Co-financed by: